Status:
COMPLETED
Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis
Lead Sponsor:
Luxembourg Institute of Health
Collaborating Sponsors:
Centre Hospitalier du Luxembourg
Hopitaux Robert Schuman (Luxembourg)
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Predi-COVID is a prospective cohort study composed of people positively tested for COVID-19 in Luxembourg, followed digitally for monitoring participants' health evolution and symptoms at home. Partic...
Detailed Description
The objective is to recruit virtually all COVID-19 positive persons in Luxembourg. The sub-sample of a minimum of 200 COVID-19 positive persons in Predi-COVID study would allow to find a risk ratio o...
Eligibility Criteria
Inclusion
- SARS-CoV-2 infection as determined by PCR, performed by one of the certified laboratories in Luxembourg
- Signed informed consent form
- Age ≥18 years old
- Hospitalized or at home
Exclusion
- Patients not understanding French or German
- Patients already included in an interventional study on Covid-19 (Discovery or other)
Key Trial Info
Start Date :
May 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
1366 Patients enrolled
Trial Details
Trial ID
NCT04380987
Start Date
May 4 2020
End Date
September 30 2024
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luxembourg Institute of Health
Luxembourg, Luxembourg